Global Meningitis Vaccines Market to Surpass US$ 6,669.3 Million by 2030
/PRNewswire/ -- According to Coherent Market Insights, the global meningitis vaccines market is estimated to be valued at US$ 4,070.1 million in 2022 and is...
Stay updated with breaking news from Espromed Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to Coherent Market Insights, the global meningitis vaccines market is estimated to be valued at US$ 4,070.1 million in 2022 and is...
<p>Currently, Venezuela and Russia have 20 cooperation agreements, one of which refers to the supply of COVID-19 vaccines.</p>
CARACAS (Sputnik) - Moscow has delivered 2.5 million influenza vaccines, produced at a Nicaragua-based Russian biopharmaceutical plant, to Venezuela, Russian... 19.05.2022, Sputnik International
Life-saving insulin to be produced by Venezuela under Russian license | Photo: Geropharm CARACAS, Venezuela, (teleSUR) — Mainstream media have not told you this: Venezuelan laboratories will manufacture millions of insulin drug capsules over the next five years, under an agreement between the government of Venezuela and the Russian biotechnology company Geropharm, reported teleSUR. According to a press release from Geropharm, the plant will be established at the facilities of the Socialist company for the Production of Biological Medicines (Espromed Bio) in Caracas. Geropharm will provide ...